Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers
The Radium Hospital Oslo University Hospital Estimated date of first patient enrolled: 3rd quarter 2021 Anticipated recruitment period: 4 years Estimated date of last patient completed: 4th quarter 2025
Locally advanced pelvic cancer that requires total pelvic exenteration
Expected study-specific follow-up period per patient: 5 years according to standard follow-up for this patient group
Primary endpoint:
R0 resection rate (circumferential resection margin \>1mm)
Secondary endpoints:
Rate of conversion to open surgery, peri- and postoperative complications, hospital length of stay, wound healing at 3 months follow-up, Quality of Life measured by EORTC Quality of Life Questionnaire C-30 preoperatively, at 3 months and 3 year follow-ups, disease-free survival, overall survival.
Diagnosis specific endpoints.
Open label observational study.
Gender: All
Ages: 18 Years - Any
Locally Advanced Pelvic Cancer That Require Pelvic Exenteration